AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
33 hedge funds and large institutions have $28.5M invested in Agile Therapeutics, Inc in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+9
Holders Change %
+37.5%
% of All Funds
0.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
6
Reduced
3
Closed
5
Calls
$61K
Puts
–
Net Calls
+$61K
Net Calls Change
-$156K
Top Buyers
1 |
PA
Perceptive Advisors
New York
|
+$2.73M |
2 |
DM
Deerfield Management
New York
|
+$1.89M |
3 |
EP
Eversept Partners
New York
|
+$1.08M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$699K |
5 |
6CM
683 Capital Management
New York
|
+$444K |
Top Sellers
1 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.21M |
2 |
FI
Fosun International
Hong Kong,
China
|
-$580K |
3 |
![]()
JPMorgan Chase & Co
New York
|
-$108K |
4 |
NIM
Needham Investment Management
New York
|
-$46.4K |
5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$21.3K |